BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10203059)

  • 1. Humanisation and characterisation of PR1A3, a monoclonal antibody specific for cell-bound carcinoembryonic antigen.
    Stewart LM; Young S; Watson G; Mather SJ; Bates PA; Band HA; Wilkinson RW; Ross EL; Snary D
    Cancer Immunol Immunother; 1999 Feb; 47(6):299-306. PubMed ID: 10203059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An epitope on carcinoembryonic antigen defined by the clinically relevant antibody PR1A3.
    Durbin H; Young S; Stewart LM; Wrba F; Rowan AJ; Snary D; Bodmer WF
    Proc Natl Acad Sci U S A; 1994 May; 91(10):4313-7. PubMed ID: 7514303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted killing of colorectal cancer cell lines by a humanised IgG1 monoclonal antibody that binds to membrane-bound carcinoembryonic antigen.
    Conaghan P; Ashraf S; Tytherleigh M; Wilding J; Tchilian E; Bicknell D; Mortensen NJ; Bodmer W
    Br J Cancer; 2008 Apr; 98(7):1217-25. PubMed ID: 18349843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specificity of anti-carcinoembryonic antigen monoclonal antibodies and their effects on CEA-mediated adhesion.
    Zhou H; Stanners CP; Fuks A
    Cancer Res; 1993 Aug; 53(16):3817-22. PubMed ID: 7687926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of colorectal tumor targeting using a novel biparatopic monoclonal antibody against carcinoembryonic antigen in experimental radioimmunoguided surgery.
    Kim JC; Roh SA; Koo KH; Ryu JH; Hong HK; Oh SJ; Ryu JS; Kim HJ; Bodmer WF
    Int J Cancer; 2002 Feb; 97(4):542-7. PubMed ID: 11802220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of carcinoembryonic antigen and its predicted immunoglobulin-like domains in HeLa cells for epitope analysis.
    Hefta LJ; Chen FS; Ronk M; Sauter SL; Sarin V; Oikawa S; Nakazato H; Hefta S; Shively JE
    Cancer Res; 1992 Oct; 52(20):5647-55. PubMed ID: 1382844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloning of the genes for T84.66, an antibody that has a high specificity and affinity for carcinoembryonic antigen, and expression of chimeric human/mouse T84.66 genes in myeloma and Chinese hamster ovary cells.
    Neumaier M; Shively L; Chen FS; Gaida FJ; Ilgen C; Paxton RJ; Shively JE; Riggs AD
    Cancer Res; 1990 Apr; 50(7):2128-34. PubMed ID: 2107969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic and affinity constants of epitope specific anti-carcinoembryonic antigen (CEA) monoclonal antibodies for CEA and engineered CEA domain constructs.
    Hefta LJ; Neumaier M; Shively JE
    Immunotechnology; 1998 Jun; 4(1):49-57. PubMed ID: 9661814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinoembryonic antigen-immunoglobulin Fc fusion protein (CEA-Fc) for identification and activation of anti-CEA immunoglobulin-T-cell receptor-modified T cells, representative of a new class of Ig fusion proteins.
    Ma Q; DeMarte L; Wang Y; Stanners CP; Junghans RP
    Cancer Gene Ther; 2004 Apr; 11(4):297-306. PubMed ID: 15002034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CEA/CD3-bispecific antibody MEDI-565 (MT111) binds a nonlinear epitope in the full-length but not a short splice variant of CEA.
    Peng L; Oberst MD; Huang J; Brohawn P; Morehouse C; Lekstrom K; Baeuerle PA; Wu H; Yao Y; Coats SR; Dall'Acqua W; Damschroder M; Hammond SA
    PLoS One; 2012; 7(5):e36412. PubMed ID: 22574157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humanised IgG1 antibody variants targeting membrane-bound carcinoembryonic antigen by antibody-dependent cellular cytotoxicity and phagocytosis.
    Ashraf SQ; Umana P; Mössner E; Ntouroupi T; Brünker P; Schmidt C; Wilding JL; Mortensen NJ; Bodmer WF
    Br J Cancer; 2009 Nov; 101(10):1758-68. PubMed ID: 19904275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A reference of the GOLD classification of monoclonal antibodies against carcinoembryonic antigen to the domain structure of the carcinoembryonic antigen molecule.
    Murakami M; Kuroki M; Arakawa F; Kuwahara M; Oikawa S; Nakazato H; Matsuoka Y
    Hybridoma; 1995 Feb; 14(1):19-28. PubMed ID: 7768530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune responses in advanced colorectal cancer following repeated intradermal vaccination with the anti-CEA murine monoclonal antibody, PR1A3: results of a phase I study.
    Zbar AP; Thomas H; Wilkinson RW; Wadhwa M; Syrigos KN; Ross EL; Dilger P; Allen-Mersh TG; Kmiot WA; Epenetos AA; Snary D; Bodmer WF
    Int J Colorectal Dis; 2005 Sep; 20(5):403-14. PubMed ID: 15864608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epitope mapping of the carcinoembryonic antigen with various related recombinant proteins expressed in Chinese hamster ovary cells and 25 distinct monoclonal antibodies.
    Ikeda S; Kuroki M; Haruno M; Oikawa S; Nakazato H; Kosaki G; Matsuoka Y
    Mol Immunol; 1992 Feb; 29(2):229-40. PubMed ID: 1371822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibodies for carcinoembryonic antigen and related antigens as a model system: determination of affinities and specificities of monoclonal antibodies by using biotin-labeled antibodies and avidin as precipitating agent in a solution phase immunoassay.
    Wagener C; Clark BR; Rickard KJ; Shively JE
    J Immunol; 1983 May; 130(5):2302-7. PubMed ID: 6187848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a transgenic mouse model for anti-human CEA radioimmunotherapeutics.
    Wilkinson RW; Ross EL; Ellison D; Zimmermann W; Snary D; Mather SJ
    J Nucl Med; 2002 Oct; 43(10):1368-76. PubMed ID: 12368376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies to carcinoembryonic antigen: a systematic analysis of antibody specificities by using related normal antigens and evidence for allotypic determinants on carcinoembryonic antigen.
    Kuroki M; Kuroki M; Koga Y; Matsuoka Y
    J Immunol; 1984 Oct; 133(4):2090-7. PubMed ID: 6206151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterisation of a humanised bispecific monoclonal antibody for cancer therapy.
    Bruynck A; Seemann G; Bosslet K
    Br J Cancer; 1993 Mar; 67(3):436-40. PubMed ID: 8439495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding reactivity of monoclonal anti-carcinoembryonic antigen (CEA) antibodies with cell membrane-bound CEA and with free CEA in solution.
    Murakami M; Kuroki M; Arakawa F; Haruno M; Kuwahara M; Ozaki H; Senba T; Matsuoka Y
    Immunol Invest; 1996; 25(1-2):23-35. PubMed ID: 8675232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applicability of carcinoembryonic antigen-specific monoclonal antibodies to radioimmunoguided surgery for human colorectal carcinoma.
    Kim JC; Kim WS; Ryu JS; Oh SJ; Lee DH; Koo KH; Roh SA; Kim HC; Yu CS; Kang GH; Bodmer WF
    Cancer Res; 2000 Sep; 60(17):4825-9. PubMed ID: 10987293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.